2 Healthcare Dividend Stocks to Hold for the Long Haul

In the ever-evolving landscape of healthcare investing, finding companies that balance growth and income generation is crucial for long-term investors. AbbVie Inc. (ABBV) and Amgen Inc. (AMGN) are two healthcare dividend stocks that have consistently demonstrated their ability to deliver both capital appreciation and attractive yields.

AbbVie Inc. (ABBV) has a strong track record of dividend growth, with a 5-year dividend growth rate of 10.2%. Its robust pipeline, including innovative therapies like epcoritamab, positions the company well for future growth. ABBV's dividend payout ratio of 35.7% indicates room for further increases, while its 5.6% dividend yield provides attractive income for investors.

Amgen Inc. (AMGN) is another healthcare dividend stock that has consistently increased its dividends, with a 5-year dividend growth rate of 9.5%. AMGN's focus on biologics and innovative therapies, such as Aimovig and Otezla, enables it to maintain a competitive edge in the market. With a dividend payout ratio of 42.9% and a 3.2% dividend yield, AMGN offers a compelling combination of growth and income.

Both ABBV and AMGN have maintained stable dividend payout ratios over the past decade, indicating a commitment to returning capital to shareholders. As their earnings continue to grow, driven by strong product pipelines and market demand, investors can expect steady dividend increases in the future.

To further illustrate the dividend growth and payout ratios of ABBV and AMGN, the following table provides a comparison with their peers and the broader market:

| Company | 5-Year Dividend Growth Rate | Dividend Yield | Dividend Payout Ratio |
| --- | --- | --- | --- |
| AbbVie Inc. (ABBV) | 10.2% | 5.6% | 35.7% |
| Amgen Inc. (AMGN) | 9.5% | 3.2% | 42.9% |
| S&P 500 Average | 7.5% | 1.6% | 50.0% |



In conclusion, AbbVie Inc. (ABBV) and Amgen Inc. (AMGN) are two healthcare dividend stocks that offer attractive long-term investment opportunities. Their strong pipelines, consistent dividend growth, and stable payout ratios make them well-positioned to deliver both capital appreciation and income for investors. As the healthcare sector continues to evolve, these companies' commitment to innovation and shareholder value ensures their place among the top dividend stocks for long-term investors.